A study to verify the efficacy of the selective SGLT2 inhibitor tofogliflozin hydrate in reducing nocturia
Not Applicable
Recruiting
- Conditions
- octuria coexisting with diabetes
- Registration Number
- JPRN-UMIN000049753
- Lead Sponsor
- Department of Urology, Kouseikai Takai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
HbA1c >8.5% eGFR <45 mL/min/1.73m^2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in nocturnal micturition frequency after 4 weeks
- Secondary Outcome Measures
Name Time Method (1) Changes after 4 weeks: 24-hour urine volume, nocturnal urine volume, nocturnal polyuria index, N-QOL, PSQI (2) Comparison at enrollment and 4 weeks later: HbA1c, serum Na